Radiation Therapy Chemotherapy Combination Improves Survival in Adults with Low-Grade Brain Cancer
ROCHESTER, Minn. — Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial, Radiation Therapy Oncology Group (RTOG) 9802 [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Glioma | Hospital Management | Neurology | Radiation Therapy